Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Masetti M, Al-Batran SE, Goetze TO, Thuss-Patience P, Knorrenschild JR, Goekkurt E, Folprecht G, Ettrich TJ, Lindig U, Luley KB, Pink D, Dechow T, Sookthai D, Junge S, Loose M, Pauligk C, Lorenzen S. Masetti M, et al. Among authors: lorenzen s. Int J Cancer. 2024 Jun 15;154(12):2142-2150. doi: 10.1002/ijc.34894. Epub 2024 Mar 6. Int J Cancer. 2024. PMID: 38447003 Clinical Trial.
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
Heise C, Nieto AE, Scheck MK, Ekmekciu I, Sommerhäuser G, Reinacher-Schick A, Hofheinz RD, Lorenzen S, Wege H, Kunzmann V, Götze TO, Mavroeidi IA. Heise C, et al. Among authors: lorenzen s. Oncol Res Treat. 2024;47(5):233-237. doi: 10.1159/000537935. Epub 2024 Feb 22. Oncol Res Treat. 2024. PMID: 38387453 No abstract available.
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023.
Kitagawa Y, Matsuda S, Gotoda T, Kato K, Wijnhoven B, Lordick F, Bhandari P, Kawakubo H, Kodera Y, Terashima M, Muro K, Takeuchi H, Mansfield PF, Kurokawa Y, So J, Mönig SP, Shitara K, Rha SY, Janjigian Y, Takahari D, Chau I, Sharma P, Ji J, de Manzoni G, Nilsson M, Kassab P, Hofstetter WL, Smyth EC, Lorenzen S, Doki Y, Law S, Oh DY, Ho KY, Koike T, Shen L, van Hillegersberg R, Kawakami H, Xu RH, Wainberg Z, Yahagi N, Lee YY, Singh R, Ryu MH, Ishihara R, Xiao Z, Kusano C, Grabsch HI, Hara H, Mukaisho KI, Makino T, Kanda M, Booka E, Suzuki S, Hatta W, Kato M, Maekawa A, Kawazoe A, Yamamoto S, Nakayama I, Narita Y, Yang HK, Yoshida M, Sano T. Kitagawa Y, et al. Among authors: lorenzen s. Gastric Cancer. 2024 May;27(3):401-425. doi: 10.1007/s10120-023-01457-3. Epub 2024 Feb 22. Gastric Cancer. 2024. PMID: 38386238 Free PMC article. No abstract available.
[Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract. German version].
Baretton G, Lordick F; Die Interdisziplinäre Expertengruppe; Gaiser T, Hofheinz R, Horst D, Lorenzen S, Möhler M, Röcken C, Schirmacher P, Stahl M, Thuss-Patience P, Tiemann K. Baretton G, et al. Among authors: lorenzen s. Pathologie (Heidelb). 2024 Feb;45(1):51-58. doi: 10.1007/s00292-023-01215-3. Epub 2024 Jan 3. Pathologie (Heidelb). 2024. PMID: 38170268 Free PMC article. Review. German.
186 results